Quick Answer
PLUS THERAPEUTICS, INC. reported Cash And Cash Equivalents At Carrying Value of $4.26 million for the year ending 2025.
- PLUS THERAPEUTICS, INC. showed an increase of +5,500.0% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from PLUS THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 18 years of available data (2008 to 2025), PLUS THERAPEUTICS, INC.'s Cash And Cash Equivalents At Carrying Value has declined by 66.3%.
- Historical annual values: Fiscal year 2025: $4.26 million | Fiscal year 2024: $76.0 thousand | Fiscal year 2023: $8.55 million | Fiscal year 2022: $18.12 million | Fiscal year 2021: $18.40 million | Fiscal year 2020: $8.35 million | Fiscal year 2019: $17.55 million | Fiscal year 2018: $5.26 million | Fiscal year 2017: $9.55 million | Fiscal year 2016: $12.60 million | Fiscal year 2015: $14.34 million | Fiscal year 2014: $14.62 million | Fiscal year 2013: $15.51 million | Fiscal year 2012: $25.72 million | Fiscal year 2011: $36.92 million | Fiscal year 2010: $52.67 million | Fiscal year 2009: $12.85 million | Fiscal year 2008: $12.61 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: